Brind.

Sanofi and ALX Oncology announced a partnership regarding a randomized Phase 1/2 clinical study.

1 report, 1 independent Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sanofi and ALX Oncology announced a partnership regarding a randomized Phase 1/2 clinical study.

Who's involved

What this event is mainly about
Sanofi

Keep exploring

The entities involved

  • Sanofi

    company in Milan, Italy

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GuruFocus.comALX Oncology Holdings Inc (ALXO) Q2 2025 Earnings Call Highlights: Promising Trial Results and ... Cash Runway Guidance: Extended into Q1 2027. ASPEN-06 Trial Results: 65% ORR in CD47-high and HER2-p